Genetic Data Security: Ban on Contracts with Foreign Biotechnology Companies
This Act aims to protect sensitive American genetic data by prohibiting executive agencies from contracting with specific foreign biotechnology companies deemed a national security risk. This means that the equipment and services of these companies cannot be used in federal contracts, enhancing the security of citizens' health information. The law also establishes a process for identifying and blocking other entities that might collect genetic data without informed consent.
Key points
Federal agencies are prohibited from procuring or using equipment and services from designated biotechnology companies of concern.
Four specific companies (BGI, MGI, Complete Genomics, WuXi AppTec) and their affiliates are initially named as companies of concern.
The goal is to protect US citizens' multiomic (genetic) data from access and exploitation by foreign governments and their intelligence agencies.
The prohibitions also extend to subcontractors and grant recipients who use the banned equipment in performing government contracts.
Status:
Expired
Record your position for audit.
Why does your vote on bills matter?
It creates raw, undeniable proof. Civic Will provides the permanent data to verify the Government's loyalty towards its citizens
(explained here).
Start recording it now.